ORIGIO a/s is a world leader in Assisted Reproductive Technology (ART) solutions. Through research and innovation, ORIGIO aims to provide the best products to medical professionals to help the #1 dream of every infertile couple come true. ORIGIO currently comprises the three product families MediCult Media, Humagen Pipets and MidAtlantic Devices, that cater for the broadest range of ART solutions. ORIGIO, which is headquartered in Jyllinge, Denmark and has companies in 9 countries, is listed on the Oslo Stock Exchange under the tickersymbol ‘ORO’.